Universidad Peruana Cayetano Heredia

ListarArtículos en revistas indizadas por tema "treatment failure"

ListarArtículos en revistas indizadas por tema "treatment failure"

Ordenar por:Orden:Resultados:

  • A Case-Control Study on the Association Between Intestinal Helminth Infections and Treatment Failure in Patients With Cutaneous Leishmaniasis 
    Martínez, Dalila Y.; Llanos Cuentas, Elmer Alejandro; Dujardin, Jean-Claude; Polman, Katja; Adaui, Vanessa; Boelaert, Marleen; Verdonck, Kristien (Oxford University Press, 2020)
    BACKGROUND: Endemic regions of cutaneous leishmaniasis (CL) and intestinal helminthiasis overlap. CL treatment with systemic pentavalent antimonial drugs (Sb(5+)) fails in 10%-30% of patients. The study objective was to ...
  • Community-acquired pneumonia in critically ill very old patients: A growing problem 
    Cillóniz, C.; Dominedò, C.; Pericàs, J.M.; Rodriguez-Hurtado, D.; Torres, A. (European Respiratory Society, 2020)
    Very old (aged ≥80 years) adults constitute an increasing proportion of the global population. Currently, this subgroup of patients represents an important percentage of patients admitted to the intensive care unit. ...
  • Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: An observational cohort study 
    Cesar, C.; Jenkins, C.A.; Shepherd, B.E.; Padgett, D.; Mejía Cordero, Fernando Alonso; Ribeiro, S.R.; Cortes, C.P.; Pape, J.W.; Sierra Madero, J.; Fink, V.; Sued, O.; McGowan, C.; Cahn, P.; Grinsztejn, B.; Reyes, M.W.; Gotuzzo Herencia, José Eduardo; CCASAnet (Elsevier, 2015)
    Background: Access to combination antiretroviral therapy (ART) is expanding in Latin America (Mexico, Central America, and South America) and the Caribbean. We assessed the incidence of and factors associated with regimen ...
  • Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions 
    Valencia, C.; Arévalo Zelada, Jorge Luis; Dujardin, J.C.; Llanos Cuentas, Elmer Alejandro; Chappuis, F.; Zimic-Peralta, Mirko Juan (Public Library of Science, 2012)
    Background: Increased rates for failure in leishmaniasis antimony treatment have been recently recognized worldwide. Although several risk factors have been identified there is no clinical score to predict antimony therapy ...
  • Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results 
    Pan, Hongchao; Peto, Richard; Henao-Restrepo, Ana-Maria; Preziosi, Marie-Pierre; Sathiyamoorthy, Vasee; Abdool Karim, Quarraisha; Alejandria, Marissa M.; Hernández García, César; Kieny, Marie-Paule; Malekzadeh, Reza; Murthy, Srinivas; Reddy, K. Srinath; Roses Periago, Mirta; Abi Hanna, Pierre; Ader, Florence; Al-Bader, Abdullah M.; Alhasawi, Almonther; Allum, Emma; Alotaibi, Athari; Alvarez-Moreno, Carlos A.; Appadoo, Sheila; Asiri, Abdullah; Aukrust, Pål; Barratt-Due, Andreas; Bellani, Samir; Branca, Mattia; Cappel-Porter, Heike B. C.; Cerrato, Nery; Chow, Ting S.; Como, Najada; Eustace, Joe; Garcia Funegra, Patricia Jannet; Godbole, Sheela; Gotuzzo Herencia, José Eduardo; Griskevicius, Laimonas; Hamra, Rasha; Hassan, Mariam; Hassany, Mohamed; Hutton, David; Irmansyah, Irmansyah; Jancoriene, Ligita; Kirwan, Jana; Kumar, Suresh; Lennon, Peter; Lopardo, Gustavo; Lydon, Patrick; Magrini, Nicola; Maguire, Teresa; Manevska, Suzana; Manuel, Oriol; McGinty, Sibylle; Medina, Marco T.; Mesa Rubio, María L.; Miranda-Montoya, Maria C.; Nel, Jeremy; Nunes, Estevao P.; Perola, Markus; Portolés, Antonio; Rasmin, Menaldi R.; Raza, Aun; Rees, Helen; Reges, Paula P. S.; Rogers, Chris A.; Salami, Kolawole; Salvadori, Marina I.; Sinani, Narvina; Sterne, Jonathan A. C.; Stevanovikj, Milena; Tacconelli, Evelina; Tikkinen, Kari A. O.; Trelle, Sven; Zaid, Hala; Røttingen, John-Arne; Swaminathan, Soumya (Massachusetts Medical Society, 2020)
    BACKGROUND: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with ...
  • Systemic lupus erythematosus: A therapeutic challenge for the XXI century 
    Ugarte Gil, Manuel Francisco; Alarcón, Graciela S. (Springer, 2014)
    Despite significant advances in our understanding of the pathogenesis of systemic lupus erythematosus (SLE), there are only a few drugs approved by the regulatory agencies across the world for the treatment of these patients; ...
  • Treatment failure in leishmaniasis: Drug-resistance or another (epi-) phenotype? 
    Vanaerschot, Manu; Dumetz, Franck; Roy, Syamal; Ponte-Sucre, Alicia; Arévalo Zelada, Jorge Luis; Dujardin, Jean-Claude (Taylor and Francis, 2014)
    Two major leishmaniasis treatments have shown a significant decrease in effectiveness in the last few decades, mostly in the Indian subcontinent but also in other endemic areas. Drug resistance of Leishmania correlated ...
  • Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures 
    Marcos, L.; Maco, V.; Terashima, A. (Taylor and Francis, 2021)
    Introduction: The only drug effective against the infection caused by Fasciola hepatica or F. gigantica is triclabendazole (TCBZ), recommended by the WHO and recently approved by the FDA. Here, we describe the evolution ...
  • Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment 
    Coronel, J.; Roper, M. H.; Herrera, C.; Bonilla, C.; Jave, O.; Gianella, C.; Sabogal, I.; Huancaré, V.; Leo, E.; Tyas, A.; Mendoza-Ticona, A.; Caviedes, L.; Moore, David Alexander James (Elsevier, 2014)
    Drug susceptibility testing (DST) is often needed in patients clinically failing tuberculosis (TB) therapy. Most studies of phenotypic direct drug susceptibility tests, such as microscopic observation drug susceptibility ...
  • Weight variation over time and its association with tuberculosis treatment outcome: A longitudinal analysis 
    Bernabé Ortiz, Antonio; Cárcamo Cavagnaro, César Paul Eugenio; Sanchez, J.F.; Rios, J. (Public Library of Science, 2011)
    Objective: Weight variation during therapy has been described as a useful marker to predict TB treatment outcome. No previous study has used longitudinal analysis to corroborate this finding. The goal of this study was to ...

Buscar en el Repositorio


Listar

Panel de Control